2’-O-Acetyl-3’,5’-bis-O-benzoyl-6-aza-xylo uridine structure
|
Common Name | 2’-O-Acetyl-3’,5’-bis-O-benzoyl-6-aza-xylo uridine | ||
|---|---|---|---|---|
| CAS Number | 161615-21-0 | Molecular Weight | 495.44 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C24H21N3O9 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
Use of 2’-O-Acetyl-3’,5’-bis-O-benzoyl-6-aza-xylo uridine2’-O-Acetyl-3’,5’-bis-O-benzoyl-6-aza-xylo uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
| Name | 2’-O-Acetyl-3’,5’-bis-O-benzoyl-6-aza-xylo uridine |
|---|
| Description | 2’-O-Acetyl-3’,5’-bis-O-benzoyl-6-aza-xylo uridine is a purine nucleoside analog. Purine nucleoside analogs have broad antitumor activity targeting indolent lymphoid malignancies. Anticancer mechanisms in this process rely on inhibition of DNA synthesis, induction of apoptosis, etc[1]. |
|---|---|
| Related Catalog | |
| References |
| Molecular Formula | C24H21N3O9 |
|---|---|
| Molecular Weight | 495.44 |